about
A genome-wide association study identifies rs2000999 as a strong genetic determinant of circulating haptoglobin levelsEpistatic study reveals two genetic interactions in blood pressure regulation.Extension of variance components approach to incorporate temporal trends and longitudinal pedigree data analysis.Control of apolipoprotein E secretion in the human hepatoma cell line KYN-2.Growing significance of myeloperoxidase in non-infectious diseases.A multilocus genotyping assay for candidate markers of cardiovascular disease riskFamily studies: their role in the evaluation of genetic cardiovascular risk factors.Alcohol Consumption, Beverage Preference, and Diet in Middle-Aged Men from the STANISLAS StudyA common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C.Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases.Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.Early-glycation of apolipoprotein E: effect on its binding to LDL receptor, scavenger receptor A and heparan sulfates.Evaluation of urinary D-glucaric acid excretion in workers exposed to butyl glycol.Genetic profiling of human cell lines used as in vitro model to study cardiovascular pathophysiology and pharmacotoxicology.Compared effect of immunosuppressive drugs cyclosporine A and rapamycin on cholesterol homeostasis key enzymes CYP27A1 and HMG-CoA reductase.Effect of HMGCoA reductase inhibitors on cytochrome P450 expression in endothelial cell line.Lipid and lipoprotein genetic variability: an important contribution from the French health examination centers.Drug metabolizing enzymes related to laboratory medicine: cytochromes P-450 and UDP-glucuronosyltransferases.Apolipoprotein E (apoE) uptake and distribution in mammalian cell lines is dependent upon source of apoE and can be monitored in living cells.Astroglial CYP1B1 up-regulation in inflammatory/oxidative toxic conditions: IL-1beta effect and protection by N-acetylcysteine.Differential role of CYP2E1 binders and isoniazid on CYP2E1 protein modification in NADPH-dependent microsomal oxidative reactions: free radical scavenging ability of isoniazid.gamma-Glutamyltranspeptidase-dependent metabolism of 4-hydroxynonenal-glutathione conjugate.Control of apolipoprotein E secretion by 25-hydroxycholesterol and proinflammatory cytokines in the human astrocytoma cell line CCF-STTG1.Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe.Effect of apolipoprotein E on cell viability in a human neuroblastoma cell line: influence of oxidation and lipid-association.The rat, a useful animal model for pharmacological studies on apolipoprotein E.Glucuronidation in the Caco-2 human intestinal cell line: induction of UDP-glucuronosyltransferase 1*6.Chemical modification of human UDP-glucuronosyltransferase UGT1*6 by diethyl pyrocarbonate: possible involvement of a histidine residue in the catalytic process.Structure-dependent induction of bilirubin glucuronidation and lauric acid 12-hydroxylation by arylcarboxylic acids chemically related to clofibrate.Glycosylation of gamma-glutamyltransferase is modified by ethanol in H5-6 hepatoma cell line.Induction of recombinant human gamma-glutamyl transferase by sodium butyrate in transfected V79 and CHO Chinese hamster cells.Glucuronidation of 3'-azido-3'-deoxythymidine in human liver microsomes: enzyme inhibition by drugs and steroid hormones.Cloning and expression of a novel type (III) of human gamma-glutamyltransferase truncated mRNA.Association of a functional 5-HT transporter gene polymorphism with anorexia nervosa and food intake.Apolipoproteins E and C-III in apo B- and non-apo B-containing lipoproteins in middle-aged women from the Stanislas cohort: effect of oral contraceptive use and common apolipoprotein E polymorphism.Candidate gene polymorphisms in cardiovascular disease: a comparative study of frequencies between a French and an Italian population.Increased protein glycation in cerebrospinal fluid of Alzheimer's disease.Protein-lipid interactions in reconstituted high density lipoproteins: apolipoprotein and cholesterol influence.Pharmacogenomics: from cell to clinic.Serum total antioxidant status is higher in postmenopausal women and after estrogen replacement therapy.
P50
Q28731542-5CEB5B26-8A64-4B04-82CF-318DA4BC7ABBQ30425631-6BF31AE3-483A-4B25-BA5C-7935EFC8FE22Q30683122-6AD59B98-5905-4456-85ED-32839F668F6FQ32063475-0479C3E7-3CB4-4E5E-A313-B4C36ABE1165Q34578402-8741DFD4-DFA9-447F-93E4-A44DE76CBCB1Q35024990-97628F60-9E54-4EC1-A49B-BC11FDE24A35Q35042612-7EB8FFDA-EB30-451E-A982-5AE101878031Q36302406-0BAF2B8C-91E2-4C65-A920-5443089761B2Q36536068-9B82E8F3-3BA4-4734-98DA-F218D30EEA56Q37597254-E1A616E3-E6AC-4DE6-B5A8-493AB4AFD10BQ38138158-C7BA6873-6488-467C-B069-85BBEB36BB29Q38288068-948982EE-C95E-4BA1-A00C-70FE01098921Q38506801-2E0A52C2-4BA5-4BE1-B104-AA0CA9546EA4Q39907281-A8FFD063-C7FA-49B4-9B3B-C68398DCF5F2Q40129780-E7526CA9-5DC4-4C89-91D8-A27DE2E41DA3Q40130205-B05551F7-D62B-499A-9811-4F87DFEFBDE0Q40508503-B8C290AC-981D-449A-87FF-F8BFCD744FA6Q40631064-01103FE3-61CC-4217-A28F-3474570F9808Q40658415-E1248160-4B35-4F03-9735-D72E730632FAQ40673253-2F162D7C-9E8B-4B17-9D7A-FC78C0721459Q40691675-EAB14196-2A5B-4038-9032-90736FD2AC24Q40762760-505662EF-881E-4F02-8388-D06BA8CA32F1Q40770600-2EADEAAE-27DC-46ED-B051-C8116EF0EFAAQ40877276-C2823C09-90FB-4115-B4F9-A2BB0716CBAEQ40880531-4E738A44-29D0-4439-B856-FF686FDECF5AQ40950378-EDECAE36-F849-4E4D-9DDF-178F040D9A80Q41313016-4A8BCAE9-D56D-497C-BE24-DFD71D81EB70Q41482673-FAD159D7-3D67-445D-BC2C-2CC1E197CE6BQ41490443-26A8E443-AD5B-4A3D-B9A3-1B1BC00F5709Q41492045-80055970-B3BA-48DF-A7B1-D2D20344DED8Q41552797-761FFAEB-7FF1-4FDE-BBBA-1AF040723A40Q41619941-8EA0E1D8-B50C-4C03-A086-78B608499CFDQ42639709-0E983094-55F1-41B8-92E4-FB8EA11AF412Q43539788-62C45E4A-AA9E-4E4A-8FE3-0855DD2669C1Q43545528-FDB0EB99-7C01-4E8C-B2A5-51BD697CBA8BQ43600213-3D68916B-688A-43F2-9071-91A97BDD21B0Q43621390-5DE033E2-6B2C-4CE4-9EAF-83560354503EQ43785238-1C2E69AF-C436-4011-A632-DD49AC30B501Q43854010-CC505B59-2B9E-4067-856F-32702F3CB21DQ44188478-54F0DD9C-E2BF-4652-B833-BBA3122CA37D
P50
description
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Gérard Siest
@ast
Gérard Siest
@de
Gérard Siest
@en
Gérard Siest
@es
Gérard Siest
@it
Gérard Siest
@nl
Gérard Siest
@sl
type
label
Gérard Siest
@ast
Gérard Siest
@de
Gérard Siest
@en
Gérard Siest
@es
Gérard Siest
@it
Gérard Siest
@nl
Gérard Siest
@sl
prefLabel
Gérard Siest
@ast
Gérard Siest
@de
Gérard Siest
@en
Gérard Siest
@es
Gérard Siest
@it
Gérard Siest
@nl
Gérard Siest
@sl
P1006
P214
P1006
P1153
36048871200
P1280
P19
P21
P214
P2536
P27
P31
P496
0000-0002-3001-760X
P5243
siest_gerard
P569
1936-05-13T00:00:00Z
P570
2016-04-09T00:00:00Z
P735
P7859
lccn-n84102327